检索结果-南通市图书馆

Concurrent renal cell carcinoma and hematologic malignancies: Nine case reports

World Journal of Clinical Oncology 2020年第8期11卷 644-654页

作者： lisa be shields Arash Rezazadeh Kalebasty Norton Neuroscience Institute Norton HealthcareLouisvilleKY 40202United States Norton Cancer Institute Norton HealthcareLouisvilleKY 40202United States

BACKGROUND The presence of renal cell carcinoma(RCC)and hematologic malignancies(HM)in the same patient is rarely *** primary findings have been described in these patients,including male gender and lymphoid malignancy predominance,and the HM are usually diagnosed before or simultaneously with the *** is a lack of evidence about clinical outcomes in this *** report the common characteristics of 9 patients diagnosed with concurrent RCC and HM and their clinical course and response to *** SUMMARY Four(44%)patients were diagnosed with RCC prior to the HM,the diagnosis was simultaneous in 4(44%)patients,and 1(11%)patient was diagnosed with the HM prior to the *** patients were treated with cytotoxic chemotherapy or radiation between the diagnosis of RCC and *** unique features were seen in our case series,such as 3 simultaneous cancers in 1(11%)patient,a splenectomy leading to remission of diffuse large B cell lymphoma without the use of chemotherapy in 1(11%)patient,chemotherapy and rituximab for lymphoma resulting in a complete response in primary RCC in 1(11%)patient,and immunotherapy providing an excellent response for primary renal leiomyosarcoma in 1(11%)*** These findings highlight the potential role of immune system dysregulation in patients with the diagnosis of RCC and HM whereby the first malignancy predisposes to the second through an immunomodulatory *** have the potential of being confused with lymph node metastasis from kidney *** node biopsy may be necessary at the time of initial diagnosis or in cases of mixed response to ***-term medical surveillance is warranted when a patient is diagnosed with RCC or *** should be aware of the higher prevalence of male gender and lymphoid malignancy with concurrent RCC and HM and that either of these conditions may be diagnosed first or they may be diagnosed simultaneously.

关键词： Oncology Renal cell cancer Hematologic malignancy Lymphoma Immune system Immunotherapy Case report

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Metastatic clear cell renal cell carcinoma in isolated retroperitoneal lymph node without evidence of primary tumor in kidneys: A case report

引用

World Journal of Clinical Oncology 2020年第2期11卷 103-109页

BACKGROUND Retroperitoneal lymph node dissection(RPLND)plays a diagnostic,therapeutic,and prognostic role in myriad urologic malignancies,including testicular carcinoma,renal cell carcinoma(RCC),and upper urinary tract urothelial *** represents 2%of all cancers with approximately 25%of patients presenting with advanced *** cell RCC(CCRCC)is the most common RCC,accounting for 75%-80%of all *** SUMMARY A 71-year-old man presented with a history of benign prostatic *** was asymptomatic without any hematuria,pain,or other urinary symptoms.A computed tomography(CT)scan of the abdomen and pelvis showed a 1.8 cm left retroperitoneal lymph *** was no evidence of renal pathology.A core biopsy was performed of the left para-aortic lymph *** the primary tumor site was unknown,the morphological and immunohistochemical features were most consistent with CCRCC.A RPLND was performed which revealed a single mass 5.5 cm in greatest dimension with extensive *** retroperitoneal lymph node was most compatible with CCRCC.A nephrectomy was not conducted as a renal mass had not been detected on any prior imaging *** patient did not receive any type of adjuvant *** patient underwent surveillance with serial CT scans with contrast of the chest,abdomen,and pelvis for the next 5 years,all of which demonstrated no recurrent or metastatic disease and no evidence of retroperitoneal *** Our unique case emphasizes the therapeutic role of metastasectomy in metastatic CCRCC even in the absence of primary tumor in the kidneys.

关键词： Oncology Renal cell carcinoma Clear cell carcinoma Lymph node dissection Retroperitoneal Metastasis Nephrectomy without primary site Case report

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Personalized chemotherapy in clear cell adenocarcinoma of the urethra:A case report

引用

World Journal of Clinical Oncology 2020年第4期11卷 243-249页

作者： lisa B E shields Arash Rezazadeh Kalebasty Norton Neuroscience Institute Norton HealthcareLouisvilleKY 40202United States Norton Cancer Institute Norton HealthcareLouisvilleKY 40202United States

BACKGROUND Clear cell adenocarcinoma of the urethra is a rare type of aggressive cancer with a poor *** cell carcinoma of the urethra represents less than 0.02%of all malignancies in *** account for 10%of female urethral carcinomas,of which 40%are the clear cell *** the presence or absence of certain mutations through genetic testing may predict whether a patient with cancer may benefit from a particular chemotherapy *** SUMMARY A 40-year-old woman presented with a 3-year history of slow urinary flow and a 3-mo history of urinary urgency and frequency as well as gross *** abdominal and pelvic computed tomography scan demonstrated enlarged lymph nodes in the abdomen and pelvis.A biopsy of a left inguinal lymph node microscopically confirmed a metastatic adenocarcinoma of the *** genetic testing determined personalized *** was treated successfully with a non-platinum-based chemotherapy consisting of paclitaxel and *** 3 cycles of paclitaxel and bevacizumab,she attained significant clinical improvement,and response by FDG-Positron emission tomography(PET)imaging showed a definite improvement in size and metabolic *** achieved complete response after 6 cycles of therapy by PET *** patient concluded 11 cycles of paclitaxel and bevacizumab,and a subsequent PET scan confirmed progression of metastatic *** patient was then treated with two cycles of doxorubicin after which a PET scan revealed a mixed response to the *** We report the first case of a patient with metastatic clear cell adenocarcinoma of the urethra who underwent personalized chemotherapy after testing for cancer gene *** unique case represents the safe and effective use of nonplatinum-based chemotherapy in clear cell adenocarcinoma of the urethra.

关键词： Oncology Clear cell adenocarcinoma Urethra Chemotherapy Personalized Genetic testing Case report

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy

引用

World Journal of Clinical Oncology 2021年第3期12卷 183-194页

作者： lisa B E shields Michael W Daniels Nataliya Mar Arash Rezazadeh Kalebasty Norton Neuroscience Institute Norton HealthcareLouisvilleKY 40202United States Department of Bioinformatics and Biostatistics University of LouisvilleLouisvilleKY 40292United States Division of Hematology/Oncology Department of MedicineUCI Medical CenterOrangeCA 92868United States

BACKGROUND Testicular germ cell tumor(TGCT)is the most curable solid tumor and most common cancer among men 18-39 *** cisplatin-based chemotherapy has significantly lengthened the survival of patients with TGCT,it is associated with a high rate of thromboembolic events(TEE).AIM To summarize our single-center experience highlighting patients who were diagnosed with TGCT and received platinum-based chemotherapy,with special attention to those patients who suffered a *** A retrospective analysis of the medical records and imaging studies of 68 consecutive individuals who were diagnosed with TGCT and received platinumbased chemotherapy at our Institution in a metropolitan community between January 1,2014 and December 31,*** A total of 19(28%)patients experienced a TEE following orchiectomy which occurred during chemotherapy in 13(68%)of these *** with a higher pathologic stage(stage III)were significantly(P=0.023)more likely to experience a TEE compared to patients who had a lower ***,patients who were treated with 3 cycles of bleomycine,etoposide,and cisplatin and 1 cycle of etoposide and cisplatin or 4 cycles of etoposide and cisplatin were significantly 5(P=0.02)times more likely to experience a TEE compared to patients who were treated with only 3 cycles of bleomycine,etoposide,and *** Due to numerous factors that predispose to a TEE such as large retroperitoneal disease,higher clinical stage,greater number of chemotherapy cycle,central venous catheter,cigarette smoking,and possible cannabis use,high-risk ambulatory patients with TGCT treated with cisplatin-based chemotherapy may benefit from prophylactic *** studies to evaluate the safety and efficacy of prophylactic anticoagulants are warranted in this young patient population generally devoid of medical co-morbidities.

关键词： Oncology Testicular cancer Thromboembolic Cisplatin Pulmonary embolism Thromboprophylaxis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

长期运动训练对脊髓损伤大鼠功能及运动神经元形态的影响及机制

长期运动训练对脊髓损伤大鼠功能及运动神经元形态的影响及机制

引用

中华医学会第十五次全国物理医学与康复学学术会议

作者：王红星 Naikui Liu Yiping Zhang Lingxiao Deng Chen Chen lisa shields Christopher B shields 励建安 Xiaoming Xu 南京医科大学第一附属医院康复医学科 Spinal Cord and Brain Injury Research Group Stark Neurosciences Research Institute Department of Neurological Surgery Indiana University School of Medicine

＜正＞目的探讨运动训练对脊髓损伤大鼠功能及运动神经元形态影响及其机制。方法成年SD大鼠33只分为假手术组（Sham）、对照组（SCI）和训练组（SCI—Tr）。采用IH撞击器制作T9脊髓损伤模型,Sham组只暴露脊髓。SCI-Tr术后1周开始运动训...

＜正＞目的探讨运动训练对脊髓损伤大鼠功能及运动神经元形态影响及其机制。方法成年SD大鼠33只分为假手术组（Sham）、对照组（SCI）和训练组（SCI—Tr）。采用IH撞击器制作T9脊髓损伤模型,Sham组只暴露脊髓。SCI-Tr术后1周开始运动训练,共16周。采用BBB评分、网格步行、热敏和痛觉评定。取材前48h各组取4只大鼠右胫前肌（TA）、左比目鱼肌（Sol）注射BHRP示踪标记神经元。余大鼠取材前6天右TA、左Sol注射荧光金和快速兰,免疫荧光检测BDNF、Synaptophysin表达。

关键词：

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes

引用

Neural Regeneration Research 2021年第7期16卷 1359-1368页

作者： Tianci Chu lisa B.E.shields Wenxin Zeng Yi Ping Zhang Yuanyi Wang Gregory N.Barnes Christopher B.shields Jun Cai Pediatric Research Institute Department of PediatricsUniversity of Louisville School of MedicineLouisvilleKYUSA Norton Neuroscience Institute Norton HealthcareLouisvilleKYUSA Department of Spine Surgery The First Hospital of Jilin UniversityChangchunJilin ProvinceChina Department of Neurology University of Louisville School of MedicineLouisvilleKYUSA Department of Pharmacology and Toxicology University of LouisvilleLouisvilleKYUSA Department of Neurological Surgery University of Louisville School of MedicineLouisvilleKYUSA

Multiple sclerosis is an autoimmune disease in which the immune system attacks the myelin sheath in the central nervous *** is characterized by blood-brain barrier dysfunction throughout the course of multiple sclerosis, followed by the entry of immune cells and activation of local microglia and *** cells(microglia, astrocytes, and oligodendrocyte lineage cells) are known as the important mediators of neuroinflammation, all of which play major roles in the pathogenesis of multiple *** communications between glial cells affect the activities of oligodendrocyte lineage cells and influence the demyelination-remyelination process.A finely balanced glial response may create a favorable lesion environment for efficient remyelination and *** review focuses on glial response and neurodegeneration based on the findings from multiple sclerosis and major rodent demyelination *** particular, glial interaction and molecular crosstalk are discussed to provide insights into the potential cell-and molecule-specific therapeutic targets to improve remyelination and neuroregeneration.

关键词： astrocyte crosstalk demyelination glial response microglia/macrophage multiple sclerosis neurodegeneration neuroinflammation oligodendrocyte lineage cells remyelination

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Technical comments on rodent spinal cord injuries models

引用

Neural Regeneration Research 2014年第5期9卷 453-455页

作者： Zoe Zhang Yi Ping Zhang lisa B.E.shields Christopher B.shields Department of Neurosurgery University of Minnesota Norton Neuroscience Institute Norton Healthcare

Spinal cord injuries （SCI） in rodents have been created by laceration, contusion, compression, or intramedullary injection of toxic agents. The choice of an appropriate SCI model should be made for each study based on the experimental design, with care taken to avoid unintended complications such as hemorrhage. Technical comments will be made in this communication describing the 1） importance of vertebral stabi- lization, 2） injury preparation, and 3） landmarks to improve the preci- sion and reproducibility of the SCI.

关键词： SCI Technical comments on rodent spinal cord injuries models lisa Zhang

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Long-term engraftment of p18^(INK4C)-deficient hematopoietic stem cells is enhanced in the sublethally-irradiated recipients

引用

Science China(Life Sciences) 2006年第4期49卷 390-394页

作者： HUANG Paulina shields Donna Hillman Cancer Center University of Pittsburgh Pittsburgh USA

Non-myeloablative regimens for host conditioning have been widely used in clinical hematopoietic stem cell transplantation due to their reduced toxicity on the recipients. But a milder conditioning regimen may require a higher engrafting ability of donor stem cells in competing with endogenous stem cells. Thus, new strategies for enhancing the competitiveness of donor stem cells in non-myeloablative recipients would have important implications for current clinical stem cell trans- plantation. It is known that the absence of p18INK4C (p18) gene can enhance the self-renewal potential of hematopoietic stem cells (HSCs). We applied the approach of competitive bone marrow trans- plantation to evaluate the impact of p18 gene deletion on long-term engraftment of HSCs in sub- lethally irradiated hosts. We found that p18?/? HSCs had a significant advantage over wild-type HSCs during long-term engraftment in the mouse recipients that received a sub-lethal irradiation (5-Gy). The engraftment efficiency of p18?/? HSCs in the sub-lethally irradiated recipients was similar to that in the lethally irradiated (10-Gy) recipients. Our current study demonstrates that enhanced engraftment of donor HSCs in the absence of p18 does not strictly depend on the dose of irradiation used for host conditioning. Therefore, p18 might serve as a potential drug target for increasing the efficacy of stem cell transplant in the patients that are preconditioned with either a myeloablative or non-myeloablative regimen.

关键词： p18INK4C (p18), hematopoietic stem cells (HSCs), engraftment efficiency, sublethal irradiation.

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Snowball Earth is dead! Long live Snowball Earth!

引用

Episodes 2006年第4期29卷 287-288页

作者： Graham A. shields Institut für Geologie und Palaeontologie Westfaeilische-Wilhelms Universitaet Correnstr. 24 48149 Münster Germany

Ticino in southern Switzerland played host this summer to a most extraordinary meeting of minds. About eighty scientists from all over the world came together in the exquisite setting of Monte Verita to discuss possibly the coldest spell in our planet＇s long history： the Cryogenian Period. ‘Snowball Earth 2006＇ was organized by a research group at the ETH in Zurich under the leadership of Professor Philip Allen, now at Imperial College, London, and was the first conference to focus solely on this topic. The Cryogenian global freeze of about 7204535 million years ago closely preceded--some would say ominously so--the first fossil evidence for animal life on Earth, and as such has attracted the attention of natural scientists worldwide. Such a resurgence of interest in deep Earth history has not been witnessed since the great K/T boundary debate of the early 1980s. On the first day of the conference, on a hot and sultry evening during the hottest July on record, it was ice of a different kind that was being broken high above Lago Maggiore. The first hesitant introductions over chilled white wine made it clear that a tluly multidisciplinary throng had been invited for what promised to be a vigorous debate on the causes and effects of Neoproterozoic climate change. Gathered for the ＇snowball fight＇ were geologists, palaeobiologists, geochemists, geophysicists and climate modellers, all of whom would, one-by-one over the coming five days, borrow centre stage to offer their unique perspective on this most polarizing of topics.

关键词：瑞士雪球气候变化二氧化碳全球变暖环境气候问题

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases

引用

World Journal of Gastrointestinal Oncology 2015年第12期7卷 445-454页

作者： Roisin Mary Heaney Conor shields Jurgen Mulsow Peritoneal Malignancy Institute Mater Misericordiae University Hospital

Cytoreductive surgery combined with intraperitoneal chemotherapy can improve survival in appropriately selected patients with colorectal peritoneal metastases. Outcomes are best in those patients in whom a complete cytoreduction can be achieved. Unresectabledisease is however encountered in approximately one-quarter of patients at laparotomy. The merits, or otherwise, of proceeding with an incomplete cytoreduction in this setting are unclear. We performed a review of published outcomes following incomplete cytoreduction for colorectal peritoneal metastases. Using the electronic databases, Pub Med and MEDLINE, a systematic search of available literature published during the period January 1997 to September 2014 was conducted. Following application of exclusion criteria, 19 papers were identified and included in this review. These comprised fifteen case series, 3 case control studies and one randomised control trial. In the nineteen studies included in this review, 2790 patients underwent cytoreductive surgery with or without intraperitoneal chemotherapy for peritoneal metastases of colorectal origin. Of these, 1732(62%) underwent a complete cytoreduction while 986(35%) patients underwent an incomplete cytoreduction. Median survival in the complete cytoreduction group ranged from 11 to 62 mo while survival in the latter group ranged from 2.4 to 32 mo. Of the 986 patients with an incomplete cytoreduction, 331 patients received intraperitoneal chemotherapy and survival in this cohort ranged from 4.5 to 32 mo. An incomplete cytoreduction, with or without intraperitoneal chemotherapy, does not appear to confer a survival benefit. The limited available data points to a palliative benefit in a subset of patients. In the absence of high quality data, the decision as to whether or not to proceed with surgery should be made on an individual patient basis.

关键词： Colorectal carcinoma Peritoneal metastases Carcino

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：